Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy
Top Cited Papers
- 22 May 2001
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 25 (7) , 571-576
- https://doi.org/10.1016/s0145-2126(01)00028-5
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Indolinone Derivatives Inhibit Constitutively Activated KIT Mutants and Kill Neoplastic Mast CellsJournal of Investigative Dermatology, 2000
- Clustering of Activating Mutations in c-KIT’s Juxtamembrane Coding Region in Canine Mast Cell NeoplasmsJournal of Investigative Dermatology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Forefront of medical science and medical care. Malignant lymphoma and chronic inflammation.Nihon Naika Gakkai Zasshi, 1998
- W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activityNature, 1995
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Expression, Function and Activation of the Proto-oncogenec-kitProduct in Human Leukemia CellsLeukemia & Lymphoma, 1993
- The kit ligand: A cell surface molecule altered in steel mutant fibroblastsCell, 1990
- Primary structure and functional expression of rat and human stem cell factor DNAsCell, 1990